< Back to situations

[ORGANIZATION]

Takeda

Featured in 21 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [AR] [CO] [PE]

Dengue prevention and regional strategy in the Americas

10 clusters · 72 sources · last updated

Latest: Peru intensifies dengue vaccination and control measures

Health authorities and experts in Latin America continue to focus on mosquito control and prevention strategies to combat dengue, chikungunya, and zika viruses. Following previous efforts in Argentina, Paraguay, Colombia

[ACTIVE] [HEALTH] [BR]

Brazil public health immunization initiatives

2 clusters · 35 sources · last updated

Latest: Brazil issues dengue vaccine second dose call amid rising case projections

Brazil has implemented various immunization efforts to address diverse public health needs. On National Vaccination Day, the Ministry of Health and the Unified Health System (SUS) coordinated multivacination campaigns ac

[QUIET] [TECHNOLOGY] [DE] [HU] [US]

Industrial automation and robotics technological trends

2 clusters · 4 sources · last updated

Latest: Embodied AI and industrial automation trends highlighted

The industrial automation sector is experiencing technological growth and a shift toward diverse market applications. In the United States, North American robot orders saw a significant increase in 2025, with non-automot

[QUIET] [HEALTH] [US] [DE] [GB]

Eli Lilly retatrutide development and black market issues

11 clusters · 32 sources · last updated

Latest: Incretin agonists show potential in obesity treatment amid safety concerns

In early August 2026, Eli Lilly announced that its experimental obesity treatment retatrutide achieved substantial weight-loss outcomes in two phase-3 trials. Participants lost up to 22.6% of body weight over 80 weeks in

[QUIET] [TECHNOLOGY] [US] [DE] [DK]

AI and automation in antibody discovery

2 clusters · 5 sources · last updated

Latest: Danaher to launch AI-powered autonomous antibody lab in 2027

The biotechnology sector is increasingly integrating artificial intelligence and automation to enhance antibody discovery and development. In late September 2026, Ginkgo Datapoints and Apheris launched the Antibody Dev

Also covered in